English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/83236
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Unique vascular protective properties of natural products: supplements or future main-line drugs with significant anti-atherosclerotic potential?

AuthorsSlevin, Mark; Ahmed, Nessar; Wang, Qiuyu; McDowell, Garry; Badimón Maestro, Lina
Issue Date30-Apr-2012
PublisherBioMed Central
CitationVascular Cell. 2012 Apr 30;4(1):9
AbstractAbstractNatural health products (NHP) which include minerals, vitamins and herbal remedies are not generally considered by medical practitioners as conventional medicines and as such are not frequently prescribed by health centre’s as either main-line or supplemental treatments. In the field of cardiovascular medicine, studies have shown that typically, less than half of patients suffering from coronary syndromes chose to take any form of NHP supplement and these products are rarely recommended by their medical practitioner. Vascular/endothelial cell damage is a key instigator of coronary arterial plaque development which often culminates in thrombosis and myocardial infarction (MI). Current treatment for patients known to be at risk of primary or secondary (MI) includes lipid lowering statins, anti-clotting agents (e.g. tissue plasminogen activator; tPA) and drugs for stabilization of blood pressure such as beta-blockers. However, evidence has been building which suggests that components of at least several NHP (e.g. aged garlic extract (AGExt), resveratrol and green tea extracts (GTE)) may have significant vascular protective effects through reduction of oxidative stress, lowering of blood pressure, reduction in platelet aggregation, vasodilation and inhibition of abnormal angiogenesis. Therefore, in this review we will discuss in detail the potential of these substances (chosen on the basis of their potency and complimentarity) as anti-atherosclerotic agents and the justification for their consideration as main-line additional supplements or prescriptions.
URIhttp://hdl.handle.net/10261/83236
Identifiershttp://dx.doi.org/10.1186/2045-824X-4-9
Appears in Collections:(CIC) Artículos
Files in This Item:
File Description SizeFormat 
2045-824X-4-9.xml67,79 kBXMLView/Open
2045-824X-4-9.pdf600,67 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.